Anthony Stein

5PUBLICATIONS
28CO-AUTHORS
Innate immunityHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseasesGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 13, 2025
First-line tagraxofusp induces durable responses with prolonged survival in adults younger than 50 years with blastic plasmacytoid dendritic cell neoplasm: Post hoc analysis of a phase 2 trial.

Anthony S Stein, Andrew A Lane, Kendra L Sweet

|Apr 18, 2024
High remission rates and transition to allogeneic transplant in older patients with newly diagnosed FLT-3 mutated acute myelogenous leukemia with midostaurin plus intensive chemotherapy.

Jose Tinajero, Dat Ngo, Jianying Zhang

|Oct 18, 2022
Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL.

Ibrahim Aldoss, Samer K Khaled, Xiuli Wang

|Dec 09, 2021
Long-term follow-up of patients with poor-risk acute leukemia treated on a phase 2 trial undergoing intensified conditioning regimen prior to allogeneic hematopoietic cell transplantation.

Amandeep Salhotra, Dongyun Yang, Sally Mokhtari

|Feb 25, 2021
Venetoclax-containing regimens in acute myeloid leukemia.

Ibrahim Aldoss, Vinod Pullarkat, Anthony S Stein

Pageof 1

Frequent Collaborators

3 joint publications

Amandeep Salhotra

2 joint publications

Ibrahim Aldoss

2 joint publications

Vinod Pullarkat

2 joint publications

Stephen J Forman